前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：201702239532429651 整理番号：17A1707038

白金療法(ARIEL3)への応答後の再発性卵巣癌に対するルカパリブ維持療法:無作為化,二重盲検,プラセボ対照,第3相試験【Powered by NICT】

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

著者 (34件)：

Coleman Robert L

(Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA)

Oza Amit M

(Department of Medicine, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada)

Lorusso Domenica

(Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies and Gynecologic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy)

Aghajanian Carol

(Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

Oaknin Ana

(Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain)

Dean Andrew

(Department of Oncology, St John of God Subiaco Hospital, Subiaco, WA, Australia)

Colombo Nicoletta

(Gynecologic Cancer Program, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy)

Weberpals Johanne I

(Ottawa Hospital Research Institute, Ottawa, ON, Canada)

Clamp Andrew

(Department of Medical Oncology, Christie National Health Service Foundation Trust and University of Manchester, Manchester, UK)

Scambia Giovanni

(Gynecologic Oncology, Universita Cattolica Roma, Rome, Italy)

Leary Alexandra

(Group d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens et du sein and Gynecological Unit, Department of Medicine, Gustave Roussy Cancer Center and Institut National de la Sante et de la Recherche Medicale U981, Villejuif, France)

Holloway Robert W

(Department of Gynecologic Oncology, Florida Hospital Cancer Institute, Orlando, FL, USA)

Gancedo Margarita Amenedo

(Medical Oncology Department, Oncology Center of Galicia, La Coruna, Spain)

Fong Peter C

(Medical Oncology Department, Auckland City Hospital, Grafton, Auckland, New Zealand)

Goh Jeffrey C

(Department of Oncology, Cancer Care Services, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia)

O’Malley David M

(Gynecologic Oncology, Ohio State University, James Cancer Center, Columbus, OH, USA)

Armstrong Deborah K

(Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA)

Garcia-Donas Jesus

(HM Hospitales-Centro Integral Oncologico Hospital de Madrid Clara Campal, Madrid, Spain)

Swisher Elizabeth M

(Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA)

Floquet Anne

(Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens et du sein and Institut Bergonie, Bordeaux, France)

Konecny Gottfried E

(Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA)

McNeish Iain A

(Institute of Cancer Sciences, University of Glasgow, Glasgow, UK)

Scott Clare L

(Royal Melbourne Hospital, Parkville, VIC, Australia)

Cameron Terri